Latest Compendiums

Cell culture is an essential component in the manufacture of vaccines, therapeutic proteins and antibodies. So, to maintain product consistency and improve quality, researchers must fine tune at each step to maximize the potential of the cell line.

In this compendium, Technology Networks presents a collection of handpicked resources, including infographics, listicles, an article and webinar, that will help you to learn more about the latest advancements with disease modeling and cancer immunotherapies.

In the pharmaceutical and biopharmaceutical realm, continuous analysis is vital for development and to ensure products are and remain safe. Technological innovations help the industry to grapple with analytical challenges and optimize therapeutics manufacturing.

This compendium highlights key examples of lipid and fatty acid analysis across a range of commercial applications and workflows.

In this compendium Technology Networks presents a collection of handpicked informative resources including articles, industry insights, a listicle and whitepaper that cover some of the latest challenges and opportunities in the quality control space.

Download this compendium to learn more about developments in high-throughput screening, target-based drug discovery and fragment-based drug discovery.

Discover a system that brings the ease of compound tuning, and the specificity of mass spectrometry, into the throughput realm of plate readers.

We are delighted to present this unique series of exclusive Ask Me Anything virtual sessions that explore a variety of STEM research and analysis topics. In each session, world-leading experts answer your questions about their research and broader topics across their field.

Most tandem mass spectrometry applications today use collision induced dissociation, which has proven to be an invaluable tool.

It was the mRNA vaccine that led the charge against SARS-CoV-2 in the recent pandemic, but now researchers are asking: what other therapeutic applications could benefit from mRNA technology?